Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
AO/PI Double Staining Kit for Cell Fate
2026-08-15
Rapidly distinguish viable, apoptotic, and necrotic cells in one fluorescent workflow. The AO/PI Double Staining Kit is especially useful for drug-response studies where membrane integrity alone cannot explain changing cell populations.
-
EZ Cap™ Cas9 mRNA: Precision Assay Design
2026-08-14
EZ Cap™ Cas9 mRNA (m1Ψ) combines a Cap1 structure, modified uridine chemistry, and a poly(A) tail for transient CRISPR-Cas9 genome editing. This guide focuses on a less discussed variable—Cas9 mRNA availability and nuclear export—and shows how to design assays that distinguish delivery, expression, and editing specificity.
-
AO/PI Double Staining Kit for Rare-Cell QC
2026-08-14
The AO/PI Double Staining Kit provides a rapid, two-color readout that separates viable, apoptotic, and necrotic cells in one preparation. This article shows how to use Acridine Orange Propidium Iodide staining for routine cell viability assays, rare-cell recovery checks, and troubleshooting after affinity-based capture.
-
Dorsomorphin Workflows for AMPK and BMP Studies
2026-08-13
Dorsomorphin, also called Compound C, enables reversible interrogation of AMPK-dependent metabolism, autophagy regulation, and BMP-driven differentiation. This practical guide translates a recent endothelial-cell study into assay design, dosing, controls, and troubleshooting strategies for metabolic, cardiovascular, stem-cell, and iron studies.
-
VNERi: Norepinephrine-Adjusted Septic Shock Assessment
2026-08-13
Goury and colleagues evaluated whether diastolic arterial pressure adjusted for heart rate and norepinephrine exposure could better reflect vascular responsiveness in early septic shock. Their post-hoc analysis identified VNERi as more strongly associated with mortality and organ-support-free outcomes than unadjusted pressure or simpler norepinephrine-response measures, while emphasizing that prospective validation is still required.
-
PreScission Protease for Keap1 Condensate Workflows
2026-08-12
PreScission Protease combines sequence-defined HRV 3C protease activity with a low-temperature workflow suited to fragile fusion proteins and condensate assays. This guide shows how to remove affinity tags from dKeap1 constructs, preserve assay-relevant protein behavior, and troubleshoot cleavage without confusing tag effects with genuine phase-separation biology.
-
Phytol Assays: Formulation, Isomers, and Signal Logic
2026-08-12
Phytol is more than an RXR ligand: its isomeric composition, hydrophobic formulation, metabolism, and GABAergic activity can all shape assay interpretation. This article presents a formulation-first framework that connects phytol biology with a useful, carefully bounded insight from polymer self-assembly research.
-
DAPI Workflows for PAD4 and NET Imaging
2026-08-11
Build reliable DAPI workflows for nuclear visualization, membrane-integrity screening, and NET-associated tumor research. This practical guide connects DAPI imaging and flow cytometry with the PAD4–H3cit–NETs findings reported in a tumor-inhibition study.
-
METTL16-SENP3-LTF Axis in HCC Ferroptosis
2026-08-11
Wang et al. identify a METTL16-SENP3-LTF signaling axis that connects m6A-dependent RNA regulation with iron sequestration and ferroptosis resistance in hepatocellular carcinoma. The work combines cellular, organoid, mouse-model, biochemical, and human-sample evidence, supporting this pathway as a mechanistically grounded target for ferroptosis sensitization.
-
Streptavidin-Cy3 for Biohybrid Microrobot Assays
2026-08-10
Streptavidin-Cy3 converts biotinylated antibodies, nucleic acid probes, and proteins into bright spatial readouts for tracking biohybrid microrobots in complex tumor models. This workflow pairs a high-affinity biotin-binding reagent with Cy3-compatible imaging while preserving a clear distinction between localization assays and the reference study’s therapeutic photodynamic-treatment experiments.
-
Biohybrid Microrobots for Barrier Penetration
2026-08-09
Gong and colleagues developed magnetically guided biohybrid microrobots by combining the deformable microalga Euglena gracilis with magnetic architectures. The platform couples externally controlled propulsion and deformation with autonomous tumor-tropic behavior, while retaining chlorophyll-dependent photodynamic activity and the biological functions of the living carrier.
-
Basic Protein Native PAGE Kit (K4142)
2026-08-08
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit supports native protein gel electrophoresis for proteins with pI ≤ 7.0. Its acidic-protein workflow uses non-denaturing conditions, gel sieving, and charge-dependent mobility to help preserve structure and biological activity during separation.
-
Phosphotungstic Acid Negative Stain Solution: EM
2026-08-07
Turn purified spikes, virions, bacteria, and macromolecular assemblies into high-contrast electron microscopy targets with a ready-to-use 2% negative stain. This workflow connects morphology checks to coronavirus entry research while clearly separating structural evidence from glycan-binding and antiviral conclusions.
-
Transdermal PTEN mRNA Delivery with HA-LNPs for Melanoma The
2026-08-07
This study introduces a hyaluronate-conjugated lipid nanoparticle (HA-LNP) system for non-invasive, transdermal delivery of PTEN mRNA, targeting immune-evasive melanoma. By replacing PEG with HA-DMG, the platform achieves efficient tumor suppressor gene expression, immune activation, and tumor inhibition, demonstrating a promising advance in localized mRNA-based cancer immunotherapy.
-
NADH in Metabolic and Mitochondrial Research: Applied Workfl
2026-08-06
Leverage reduced nicotinamide adenine dinucleotide (NADH) for robust interrogation of cellular energy metabolism, mitochondrial function, and redox-driven disease models. This article bridges cutting-edge protocol design, troubleshooting, and comparative insight to maximize reproducibility and innovation in NADH-based research.